Deborah Moorad

Deborah Moorad serves as the Chief Executive Officer of CorriXR Therapeutics since September 2023. Additionally, Deborah holds dual positions as a Health Tech Advisor and Entrepreneur in Residence at Cortado Ventures since October 2022. As the Founding CEO of both JAX XII HOLDINGS since February 2012 and Malibu Okie since January 2022, Deborah has demonstrated leadership in various sectors. Deborah's expertise extends to global commercialization as a consultant for The University of Texas at Austin's Global Programs since April 2016. Previously, Deborah was the Chief Executive Officer at Nature Technology Corporation from December 2018 to August 2023 and held the role of Global Strategic Senior Manager at Dentsply Sirona from December 2016 to February 2018. Deborah's earlier experience includes positions at the Oklahoma Medical Research Foundation and the University of Oklahoma Health Sciences Center focused on technology ventures and research.